BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25500455)

  • 21. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 24. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
    Zhang Y; Ding J; Hua K
    J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease.
    McCann GA; Boutsicaris CE; Preston MM; Backes FJ; Eisenhauer EL; Fowler JM; Cohn DE; Copeland LJ; Salani R; O'Malley DM
    Gynecol Oncol; 2013 Apr; 129(1):135-9. PubMed ID: 23357610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients.
    Cohen JG; Kapp DS; Shin JY; Urban R; Sherman AE; Chen LM; Osann K; Chan JK
    Am J Obstet Gynecol; 2010 Oct; 203(4):347.e1-6. PubMed ID: 20579961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic characteristics of eight patients with small cell carcinoma of the cervix].
    Cheng M; Wu LY; Bai P; Zhang R; Zheng S
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):189-92. PubMed ID: 18788567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
    Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
    BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature].
    Bellefqih S; Khalil J; Mezouri I; Kebdani T; Benjaafar N
    Cancer Radiother; 2014 Jun; 18(3):201-7. PubMed ID: 24656987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
    Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Nakanishi T; Hasumi Y; Iwata T; Baba T; Nogawa T; Kudaka W; Kaneda H; Ono S; Saito F; Taniguchi Y; Okada S; Mizuno M; Onda T; Yaegashi N
    Gynecol Oncol; 2018 Jan; 148(1):139-146. PubMed ID: 29113721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for small cell neuroendocrine carcinoma of the uterine cervix: an institutional experience.
    Intaraphet S; Kasatpibal N; Siriaunkgul S; Chandacham A; Sukpan K; Patumanond J
    Int J Gynecol Cancer; 2014 Feb; 24(2):272-9. PubMed ID: 24401981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
    Mabuchi S; Komura N; Sasano T; Sakata M; Matsuzaki S; Hisa T; Kamiura S; Morishima T; Miyashiro I
    Curr Oncol; 2023 Oct; 30(11):9428-9436. PubMed ID: 37999102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to regional lymph nodes.
    Kim YB; Barbuto D; Lagasse LD; Karlan BY
    Gynecol Oncol; 1996 Sep; 62(3):411-4. PubMed ID: 8812543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small cell neuroendocrine cervical carcinoma with 1-year follow-up: case report and review.
    Bifulco G; Mandato VD; Giampaolino P; Piccoli R; Insabato L; De Rosa N; Nappi C
    Anticancer Res; 2009 Feb; 29(2):477-84. PubMed ID: 19331190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
    Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
    Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.